NSW emergency visits tied to unapproved peptides rise to 217 a month
Retatrutide was mentioned in 71% of the 1,180 peptide-linked presentations recorded over 15 months, and 18% of visits ended in admission.
DO
By Daniel Okafor · Regulatory Correspondent
Oct 19 03:11 ETSource: The Daily Aus
The wire
- 01NSW Health reports monthly ED presentations mentioning unapproved peptides rose from five in July 2025 to 217 in September 2026, with a quarter of patients aged 16 to 24.
- 02Reported presentations included abdominal pain, vomiting and chest pain; the TGA has warned the products may be contaminated, mislabelled or stronger than advertised.
- 03Chief Health Officer Kerry Chant said websites, labels, purity claims and influencer endorsements are not proof of contents; the data are surveillance mentions, not confirmed causation.
From the source
Read at thedailyaus.com.auNSW ED visits linked to unapproved peptides jump to 217
NSW Health says monthly emergency department visits linked to unapproved peptides have climbed from five to 217 in 15 months.
